skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Please comment on Q results & guide. It dropped 7.8% to $6.12 thereafter. Bought it in early Aug,2018 @ $9.10 when it was a Top Pick on Market Call. While the current yield is 4.9%,there is expectation of higher rates by BOC. Hold on longer or sell. If sell ,please provide 2or3 good names(not necessary in the same sector). Txs for u usual great services & views
Read Answer Asked by Peter on June 10, 2022
Q: I have TCL.a in a tax-deferred account and show a significant loss — 50.1% below my cost. I cannot use the tax loss. I follow only US shares , and 95% of my folio is in US-listed companies. I do not follow Canadian markets at all and was therefore wondering why on earth I bought this awful entity.

I have no clue EXCEPT since I would buy Canadian shares only if suggested by 5i or if the security appeared in the 5i portfolio.

Was this company EVER in the 5i folio? (I do not check the Q & A section; too many questions contain a bewilderingly long—very long— list of symbols that make it tediously difficult to read).

On TCL.a I checked reports from RBC-DI , iTRADE, Thompson Reuters, Research Team, StockCalc, StockReports, CFRA and several others. RBC is the only analyst that does NOT hate it.

When I took a closer look at TCL.a , I find it has a horribly, outdated business model. It has done nothing for years, and share price has gone only down. No analyst seems to have a clue how this ancient business model can ever work.

What do you think of TCL.a ? It does not matter that I find it maddening, meaning please disregard my prejudices and my frustration with myself for buying, then holding, something I didn’t take time to review. I am looking for a fresh independent opinion.... a very FRESH opinion from you, AFTER it reports tomorrow (June 8).

Read Answer Asked by Adam on June 10, 2022
Q: Could you comment on the latest contract signed by VHI which equates to about 7% of their market cap? Thanks as always.

TORONTO, June 06, 2022 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company”) (TSX: VHI) is pleased to announce that TREAT has been licensed for an initial six-year contract term and an option to extend for four additional years, to better track the essential medical information needed to effectively treat inmates in provincially-run adult correctional institutions across Ontario.

For VitalHub, this agreement is an important and meaningful event. The six-year contract value is comprised of recurring license revenue and professional services delivered over a six-year period, totaling approximately $9 million (CAD) in the initial term.
Read Answer Asked by karl on June 09, 2022
Q: Can you give me a list of some small cap canadian companies who have good balance sheet, debt are not too high and you recommend in investing for the long term
Read Answer Asked by Kristelle on June 09, 2022
Q: I am down about 41% with both ENGH and WELL, but 2x the dollar amount for ENGH. I am considering selling 1 or both now for a tax loss and likely buying back. Any idea what to expect with ENGH's upcoming earnings report next week? ENGH seems to be currently sitting at pre-pandemic levels and I am guessing it might be there for a while unless there is some dramatic change in the economy. Thanks for your your comments!
Read Answer Asked by Grant on June 06, 2022
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!